- Filed
- Mar 15, 2022 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2021 · Mar 14, 2022 | 5.07M sh |
| Shares Diluted | FY 2021 · Dec 31, 2021 | 5.92M sh |
| Shares Diluted | FY 2021 · Dec 31, 2020 | 4.25M sh |
| Capex | FY 2021 · Dec 31, 2021 | $0 |
| Capex | FY 2021 · Dec 31, 2020 | $50.89K |
| Operating Cash Flow | FY 2021 · Dec 31, 2021 | $1.93M |
| Operating Cash Flow | FY 2021 · Dec 31, 2020 | −$2.03M |
| Cash And Equivalents | FY 2021 · Dec 31, 2021 | $37.85M |
| Cash And Equivalents | FY 2021 · Dec 31, 2020 | $48.25M |
| Stockholders Equity | FY 2021 · Dec 31, 2021 | $46.84M |
| Stockholders Equity | FY 2021 · Dec 31, 2020 | $35.49M |
| Stockholders Equity | FY 2021 · Dec 31, 2019 | $34.42M |
| Current Liabilities | FY 2021 · Dec 31, 2021 | $6.85M |
| Current Liabilities | FY 2021 · Dec 31, 2020 | $6.42M |
| Total Liabilities | FY 2021 · Dec 31, 2021 | $23.59M |
| Total Liabilities | FY 2021 · Dec 31, 2020 | $25.12M |
| Current Assets | FY 2021 · Dec 31, 2021 | $69.16M |
| Current Assets | FY 2021 · Dec 31, 2020 | $59.1M |
| Total Assets | FY 2021 · Dec 31, 2021 | $70.43M |
| Total Assets | FY 2021 · Dec 31, 2020 | $60.61M |
| Eps Diluted | FY 2021 · Dec 31, 2021 | $0.51 |
| Eps Diluted | FY 2021 · Dec 31, 2020 | −$0.44 |
| Eps Basic | FY 2021 · Dec 31, 2021 | $0.68 |
| Eps Basic | FY 2021 · Dec 31, 2020 | −$0.44 |
| Sga Expense | FY 2021 · Dec 31, 2021 | $12.15M |
| Sga Expense | FY 2021 · Dec 31, 2020 | $11.74M |
| Rd Expense | FY 2021 · Dec 31, 2021 | $16.83M |
| Rd Expense | FY 2021 · Dec 31, 2020 | $9.24M |
| Net Income | FY 2021 · Dec 31, 2021 | $3.01M |
| Net Income | FY 2021 · Dec 31, 2020 | −$1.86M |
| Operating Income | FY 2021 · Dec 31, 2021 | $5.16M |
| Operating Income | FY 2021 · Dec 31, 2020 | −$2.24M |
| Revenue | FY 2021 · Dec 31, 2021 | $47.79M |
| Revenue | FY 2021 · Dec 31, 2020 | $29.63M |